News
The documentary “Recovering Innocence,” made almost entirely by foster youth, explores the risks of psych meds — and ...
Pharmaceutically made cannabidiol targeting myocarditis did not increase cardiovascular events in at-risk patients, a ...
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
Updated Results from the Ongoing Phase 1/2a Study of MP0533, a Tetra-Specific Designed Ankyrin Repeat Protein (DARPin; CD33 x CD123 x CD70 x CD3), in Patients with Relapsed/Refractory AML or MDS/AML ...
Travere Therapeutics, Inc., today announced that the Company will present three abstracts on the effect of FILSPARI (sparsentan) in rare kidney disease at the upcoming International Podocyte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results